LabCorp announces $250 million stock repurchase program

August 11, 2009 By: NCTechNews Category: Biotechnology, Pharmaceuticals

(Burlington, N.C.) Laboratory Corporation of America® Holdings (NYSE: LH) today announced that its Board of Directors has authorized a new stock repurchase program under which LabCorp may purchase up to an aggregate of $250 million of its Common Stock from time-to-time. LabCorp purchased a total of $500 million of its Common Stock under its previously announced and completed stock repurchase program, $95.2 million of which was completed since the end of the second quarter of 2009.

Any purchases under LabCorp’s stock repurchase program may be made from time-to-time in the open market or in privately negotiated transactions and may be initiated and discontinued at any time.

Laboratory Corporation of America® Holdings, a S&P 500 company, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $4.5 billion in 2008, over 28,000 employees worldwide, and more than 220,000 clients, LabCorp offers clinical assays ranging from routine blood analyses to HIV and genomic testing. LabCorp combines its expertise in innovative clinical testing technology with its Centers of Excellence: The Center for Molecular Biology and Pathology, National Genetics Institute, Inc., ViroMed Laboratories, Inc., The Center for Esoteric Testing, Litholink Corporation, DIANON Systems, Inc., US LABS, and Esoterix and its Colorado Coagulation, Endocrine Sciences, and Cytometry Associates laboratories. LabCorp conducts clinical trial testing through its Esoterix Clinical Trials Services division. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about our organization, visit our Web site at: www.labcorp.com.

Comments are closed.

  • Packaging Cures

    RTP-based advertising and branding firm The Marketing Machine helped overcome the issue of illiteracy among medical patients in Ghana, South Africa in designing packaging for the only manufacturer of anti-retroviral drugs in the region, creating individual icons and colors to help patients understand which drugs they needed, regardless of their ability to read.

    Broadband Stimulus

    Two grants funded by the American Recovery and Reinvestment Act are being used by MCNC to expand broadband connectivity and services throughout North Carolina and create more than 1,000 engineering and construction jobs, the organization said.

    Video: QC in Pharma Mfg


    Defense Industry Gets More Competitive

    U.S. troop level decreases and shrinking armed forces budgets will lead to increased competition and a change in business operations for military contractors in North Carolina and throughout the nation, according to defense industry contracting expert Lea Strickland, requiring a more strategic and tactical approach to developing professional, properly-designed bid proposals.

    A Leg Up for Students

    Innovative concept-to-marketplace product design and development firm Montie Design is holding a Winter 2012 Student Design Contest for aspiring product designers in community colleges, four-year colleges, or high schools from North Carolina and Virginia, starting February 1.

    getting from lab 2 line

    The leader in analytical instrumentation for the pharma manufacturing industry has named a new COO responsible for manufacturing, engineering, software development, and project management for hardware and software products such as the VTT-1000 multi-variant testing device, breaking down barriers to speeding-up the drug manufacturing pipeline and cutting-down on drug shortages.

  • Recent Headlines



free web site traffic and promotion